Quest diagnostics and cdc expand public health research collaboration to better understand hepatitis c burden in the united states

Quest will provide research consulting, laboratory testing and data analytics services to generate diagnostics insights supporting population health strategy for hepatitis c secaucus, n.j. , dec. 7, 2023 /prnewswire/ -- quest diagnostics (nyse: dgx), the nation's leading provider of diagnostic information services, today announced that it has been awarded a contract by the united states centers for disease control and prevention (cdc) designed to assess the burden of hepatitis c virus (hcv) in the united states quest was awarded a multi-year agreement following a competitive bid.
DGX Ratings Summary
DGX Quant Ranking